Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 4Phase 1/2 2Phase 3 1

Status

Terminated 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 2Plasma cell 1Breast 1

Conditions

Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Glioblastoma 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Chloroquine × Clear all
NCT01894633 2024-01-24

CLQ

Instituto Nacional de Cancerologia de Mexico

Phase 2 Terminated
73 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT02432417 2023-11-18

The Addition of Chloroquine to Chemoradiation for Glioblastoma,

Maastricht Radiation Oncology

Phase 2 Withdrawn
CNS

Glioblastoma

NCT01438177 2020-02-24

Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma

NYU Langone Health

Phase 2 Terminated
11 enrolled 9 charts
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT02333890 2016-11-18

CUBiC

Ottawa Hospital Research Institute

Phase 2 Unknown
60 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡